|
Molecular Modèles, Inc. (MTEM) Valation DCF
US | Healthcare | Biotechnology | NASDAQ
|
- ✓ Entièrement Modifiable: Adapté À Vos Besoins Dans Excel Ou Sheets
- ✓ Conception Professionnelle: Modèles Fiables Et Conformes Aux Normes Du Secteur
- ✓ Pré-Construits Pour Une Utilisation Rapide Et Efficace
- ✓ Aucune Expertise N'Est Requise; Facile À Suivre
Molecular Templates, Inc. (MTEM) Bundle
Gagnez la maîtrise sur vos analyses d'évaluation Molecular Modèles, Inc. (MTEM) à l'aide de notre calculatrice sophistiquée DCF! Chargé avec de vraies données MTEM, ce modèle Excel vous permet d'ajuster les prévisions et les hypothèses pour déterminer avec précision la valeur intrinsèque de Molecular Modèles, Inc. (MTEM).
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 19.5 | 15.6 | 38.7 | 19.8 | 57.3 | 76.1 | 101.1 | 134.2 | 178.3 | 236.8 |
| Revenue Growth, % | 0 | -19.82 | 147.5 | -48.95 | 190.1 | 32.81 | 32.81 | 32.81 | 32.81 | 32.81 |
| EBITDA | -66.0 | -99.0 | -72.9 | -80.1 | 1.4 | -60.5 | -80.4 | -106.7 | -141.7 | -188.2 |
| EBITDA, % | -338.6 | -633.23 | -188.49 | -405.4 | 2.5 | -79.5 | -79.5 | -79.5 | -79.5 | -79.5 |
| Depreciation | 2.1 | 4.2 | 6.7 | 7.8 | 6.9 | 16.2 | 21.5 | 28.6 | 38.0 | 50.4 |
| Depreciation, % | 10.77 | 26.86 | 17.31 | 39.49 | 12.06 | 21.3 | 21.3 | 21.3 | 21.3 | 21.3 |
| EBIT | -68.1 | -103.2 | -79.6 | -87.9 | -5.5 | -62.3 | -82.8 | -110.0 | -146.0 | -193.9 |
| EBIT, % | -349.37 | -660.1 | -205.8 | -444.89 | -9.56 | -81.91 | -81.91 | -81.91 | -81.91 | -81.91 |
| Total Cash | 125.1 | 93.9 | 143.0 | 61.0 | 11.5 | 63.9 | 84.9 | 112.8 | 149.8 | 198.9 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | 7.5 | .2 | .0 | .0 | .3 | 6.2 | 8.2 | 10.9 | 14.4 | 19.1 |
| Account Receivables, % | 38.5 | 1.5 | 0 | 0 | 0.43625 | 8.09 | 8.09 | 8.09 | 8.09 | 8.09 |
| Inventories | 6.8 | 6.1 | .0 | .0 | .0 | 11.2 | 14.9 | 19.8 | 26.3 | 35.0 |
| Inventories, % | 34.97 | 38.89 | 0 | 0 | 0 | 14.77 | 14.77 | 14.77 | 14.77 | 14.77 |
| Accounts Payable | 1.5 | 2.4 | 1.6 | .5 | 1.5 | 4.9 | 6.5 | 8.6 | 11.4 | 15.1 |
| Accounts Payable, % | 7.51 | 15.03 | 4.17 | 2.55 | 2.66 | 6.38 | 6.38 | 6.38 | 6.38 | 6.38 |
| Capital Expenditure | -9.6 | -7.4 | -4.0 | -3.2 | -.2 | -18.8 | -25.0 | -33.2 | -44.1 | -58.5 |
| Capital Expenditure, % | -49.48 | -47.28 | -10.33 | -16.19 | -0.349 | -24.73 | -24.73 | -24.73 | -24.73 | -24.73 |
| Tax Rate, % | 0.13522 | 0.13522 | 0.13522 | 0.13522 | 0.13522 | 0.13522 | 0.13522 | 0.13522 | 0.13522 | 0.13522 |
| EBITAT | -68.2 | -103.2 | -76.1 | -87.9 | -5.5 | -61.8 | -82.0 | -108.9 | -144.7 | -192.2 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -88.6 | -97.5 | -67.8 | -84.4 | 2.0 | -78.2 | -89.6 | -119.0 | -158.1 | -209.9 |
| WACC, % | 21.7 | 21.7 | 20.73 | 21.7 | 21.67 | 21.5 | 21.5 | 21.5 | 21.5 | 21.5 |
| PV UFCF | ||||||||||
| SUM PV UFCF | -343.2 | |||||||||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | -214 | |||||||||
| Terminal Value | -1,098 | |||||||||
| Present Terminal Value | -415 | |||||||||
| Enterprise Value | -758 | |||||||||
| Net Debt | 1 | |||||||||
| Equity Value | -759 | |||||||||
| Diluted Shares Outstanding, MM | 5 | |||||||||
| Equity Value Per Share | -168.54 |
What You Will Get
- Real MTEM Financial Data: Pre-filled with Molecular Templates’ historical and projected data for precise analysis.
- Fully Editable Template: Modify key inputs like revenue growth, WACC, and EBITDA % with ease.
- Automatic Calculations: See Molecular Templates’ intrinsic value update instantly based on your changes.
- Professional Valuation Tool: Designed for investors, analysts, and consultants seeking accurate DCF results.
- User-Friendly Design: Simple structure and clear instructions for all experience levels.
Key Features
- 🔍 Real-Life MTEM Financials: Pre-filled historical and projected data for Molecular Templates, Inc.
- ✏️ Fully Customizable Inputs: Adjust all critical parameters (yellow cells) like WACC, growth %, and tax rates.
- 📊 Professional DCF Valuation: Built-in formulas calculate Molecular Templates’ intrinsic value using the Discounted Cash Flow method.
- ⚡ Instant Results: Visualize Molecular Templates’ valuation instantly after making changes.
- Scenario Analysis: Test and compare outcomes for various financial assumptions side-by-side.
How It Works
- Step 1: Download the Excel file.
- Step 2: Review pre-entered Molecular Templates, Inc. (MTEM) data (historical and projected).
- Step 3: Adjust key assumptions (yellow cells) based on your analysis.
- Step 4: View automatic recalculations for Molecular Templates, Inc. (MTEM)’s intrinsic value.
- Step 5: Use the outputs for investment decisions or reporting.
Why Choose This Calculator for Molecular Templates, Inc. (MTEM)?
- Accuracy: Utilizes actual Molecular Templates financial data for precise calculations.
- Flexibility: Allows users to easily adjust and experiment with various inputs.
- Time-Saving: Avoid the complexities of constructing a DCF model from the ground up.
- Professional-Grade: Crafted with the expertise and attention to detail expected at the CFO level.
- User-Friendly: Intuitive design makes it accessible for users with limited financial modeling skills.
Who Should Use This Product?
- Individual Investors: Gain insights to make informed decisions regarding investments in Molecular Templates, Inc. (MTEM).
- Financial Analysts: Enhance valuation processes with comprehensive financial models tailored for Molecular Templates, Inc. (MTEM).
- Consultants: Provide clients with accurate and timely valuation insights related to Molecular Templates, Inc. (MTEM).
- Business Owners: Learn about the valuation of biotech firms like Molecular Templates, Inc. (MTEM) to inform your own business strategies.
- Finance Students: Explore valuation methodologies using real-world examples from Molecular Templates, Inc. (MTEM).
What the Template Contains
- Pre-Filled Data: Includes Molecular Templates, Inc.'s (MTEM) historical financials and projections.
- Discounted Cash Flow Model: Editable DCF valuation model with automatic calculations tailored for (MTEM).
- Weighted Average Cost of Capital (WACC): A dedicated sheet for calculating WACC based on custom inputs relevant to (MTEM).
- Key Financial Ratios: Analyze (MTEM)'s profitability, efficiency, and leverage metrics.
- Customizable Inputs: Easily adjust revenue growth, profit margins, and tax rates for (MTEM).
- Clear Dashboard: Visuals and tables summarizing key valuation outcomes for (MTEM).
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.